DarioHealth Corp. DRIO

6.63 (0.14) (2.07%) as of 25 Sep
Market cap
$66.3M
P/E
0.0×
Insider Buys alert about insiders buying in the last 12 month
Dec '16 Dec '17 Dec '18 Dec '19 Dec '20 Dec '21 Dec '22 Dec '23 Dec '24 Dec '25
P/E ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/S ratio
0.29 0.15 0.12 1.97 11.25 10.49 3.72 2.36 1.43 2.03
P/FCF ratio
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
P/Operating CF
(0.44) (0.32) (0.26) (5.21) (12.61) (14.22) (12.95) (6.53) (5.73) (7.70)
P/B ratio
0.00 0.20 0.10 0.79 3.03 2.52 1.29 0.82 0.54 0.67
Price to Tangible BV
0.00 0.20 0.10 0.79 3.03 6.84 3.61 4.32 0.00 0.00
EV/Sales
(0.18) (0.62) (1.39) (0.65) 7.52 8.75 2.90 1.94 1.44 2.69
EV/EBITDA
0.05 0.23 0.59 0.28 0.00 0.00 0.00 0.00 0.00 0.00
EV/Operating CF
0.06 0.30 0.90 0.31 (3.21) (3.56) (1.68) (1.30) (1.01) (2.32)
EV/FCF
0.05 0.29 0.89 0.31 (3.19) (3.54) (1.65) (1.26) (0.99) (2.27)
Quick Ratio
0.70 1.61 2.27 4.12 4.53 2.74 2.98 3.38 2.15 3.30
Current Ratio
1.00 2.01 2.54 4.39 4.85 3.17 3.39 3.79 2.44 3.76
Net Debt/EBITDA
0.12 0.28 0.64 1.13 0.96 0.50 0.43 0.17 (0.01) (0.13)
Debt/Assets
0.00% 0.00% 0.00% 3.14% 1.50% 0.28% 22.59% 29.61% 24.33% 27.93%
Debt/Equity
0.00 0.00 0.00 0.04 0.02 0.00 0.34 0.49 0.40 0.45
Asset Turnover
0.63 0.95 0.70 0.39 0.25 0.30 0.25 0.19 0.25 0.20
Operating CF/Net income
0.72 0.66 0.63 0.75 0.54 0.64 0.75 0.48 0.94 0.42
Capex/Depreciation
(2.09) (1.00) (0.34) (0.54) (0.26) (0.06) (0.12) (0.12) (0.02) (0.05)
Interest Coverage
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
ROE
285.85% 1,230.62% (284.41%) (150.19%) (140.73%) (138.55%) (77.12%) (91.95%) (62.97%) (88.23%)
ROA
(259.40%) (295.47%) (173.87%) (108.08%) (110.39%) (115.68%) (58.04%) (58.92%) (38.07%) (53.93%)
ROIC
0.00% 0.00% 0.00% 0.00% 0.00% (95.93%) (61.85%) (70.80%) (49.91%) (31.63%)
Return on Tangible Assets
(1,272.70%) (410.21%) (211.00%) (113.74%) (119.63%) (246.68%) (135.93%) (177.72%) (166.57%) (234.80%)
Average Days of Receivables
95.06 62.55 27.05 45.34 147.33 60.09 106.19 92.88 96.38 73.54
Research and Development Expense of Revenue
76.85% 63.77% 49.72% 48.84% 58.51% 83.94% 71.05% 99.49% 89.42% 61.68%
Selling, General and Administrative Expense of Revenue
289.58% 240.48% 213.38% 219.74% 369.36% 308.28% 169.28% 206.00% 173.20% 158.90%
Intangible Assets out of Total Assets
0.00 0.00 0.00 0.00 0.00 0.54 0.43 0.49 0.64 0.67
Share Based Compensation of Revenue
37.03% 73.97% 50.82% 29.86% 146.54% 121.73% 61.38% 96.80% 58.42% 41.88%
Graham Net Nets
(9.10) 3.90 8.73 1.16 0.32 0.14 0.26 0.19 (0.16) (0.16)
Graham Number
2,992.04 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Earnings Yield
(1,251.23%) (3,369.22%) (2,061.86%) (122.97%) (40.83%) (32.23%) (60.46%) (120.13%) (112.17%) (91.65%)
Free Cash Flow Yield
(1,118.18%) (1,445.32%) (1,268.98%) (106.44%) (20.95%) (23.55%) (47.32%) (65.33%) (101.34%) (58.34%)
Revenue per Share
215.62 214.52 126.18 66.72 25.41 24.73 23.40 14.35 11.03 5.61
Operating CF per Share
(644.54) (440.62) (195.73) (138.79) (59.48) (60.76) (40.48) (21.41) (15.73) (6.51)
Capex per Share
(62.15) (8.09) (1.21) (0.86) (0.40) (0.31) (0.48) (0.41) (0.06) (0.04)
Free Cash Flow per Share
(706.69) (448.71) (196.95) (139.66) (59.87) (61.08) (40.97) (21.83) (15.78) (6.55)
Cash per Share
101.38 164.98 190.73 181.69 96.50 43.39 41.90 26.14 11.68 6.59
Shareholders Equity per Share
(503.15) 163.53 152.30 166.76 94.40 103.12 67.69 40.99 29.37 17.05
Interest Debt per Share
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Book value per Share
(503.15) 163.53 152.30 166.76 94.40 103.12 67.69 40.99 29.37 17.05
Free Cash Flow
(9.19) (10.81) (11.54) (15.82) (17.85) (50.67) (48.42) (30.96) (38.70) (26.08)
Working Capital
0.01 3.03 7.94 17.72 27.09 31.23 46.17 34.84 23.89 25.74
Capital Expenditures
(0.81) (0.19) (0.07) (0.10) (0.12) (0.26) (0.57) (0.58) (0.14) (0.14)
Net Current Asset Value
(7.48) 3.03 7.94 17.26 26.87 30.38 26.33 9.09 (6.34) (7.09)
EV/EBIT
0.04 0.22 0.58 0.28 0.00 0.00 0.00 0.00 0.00 0.00
Capex to Sales
0.29 0.04 0.01 0.01 0.02 0.01 0.02 0.03 0.01 0.01
Net Profit Margin
(414.09%) (309.44%) (247.44%) (276.37%) (436.95%) (383.98%) (230.82%) (312.06%) (151.56%) (276.11%)
Price to Operating Income
0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Other line items
Depreciation/Fixed assets
0.43 0.22 0.28 0.28 0.79 6.35 5.99 5.55 10.48 5.72
Cash ROIC
177.68% (145.11%) (60.71%) (40.68%) (31.87%) (41.95%) (31.09%) (25.27%) (30.31%) (21.21%)
Accounts Receivable Turnover
3.37 6.40 10.31 10.17 3.79 6.38 4.84 3.08 4.39 3.84
Accounts Payable Turnover
2.60 2.11 2.54 2.35 2.45 4.36 4.84 8.32 6.60 3.25
Inventory Turnover
4.88 3.72 4.40 3.56 2.73 3.88 2.54 2.21 2.81 2.14
Average Days of Payables
182.05 175.17 166.91 121.81 178.79 112.68 47.08 28.73 80.70 110.25
Days of Inventory on Hand
89.22 111.99 89.29 104.01 165.31 137.35 161.32 128.59 125.96 162.51
Average Receivables
0.83 0.81 0.72 0.74 2.00 3.22 5.71 6.61 6.16 5.82
Average Payables
1.40 1.83 2.21 2.12 2.07 3.79 3.72 1.73 2.09 2.99
Average Inventory
0.74 1.04 1.28 1.40 1.85 4.26 7.09 6.51 4.91 4.53
Average Assets
4.47 5.41 10.52 19.33 29.99 68.09 109.98 107.79 107.64 114.48
Average Common Equity
(4.06) (1.30) 6.43 13.91 23.52 56.85 82.77 69.07 65.08 69.97

Fold the line items

Columns are period end dates